PD-1 blockade augments anti-neuroblastoma immune response induced by anti-GD(2) antibody ch14.18/CHO

Immunotherapy with anti-GD(2) antibody (Ab) ch14.18/CHO is effective for treatment of high-risk neuroblastoma (NB) patients and is mainly based on GD(2)-specific Ab-dependent cellular cytotoxicity (ADCC). Strategies to further enhance the efficacy are important and currently explored in prospective...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncoimmunology
Hoofdauteurs: Siebert, Nikolai, Zumpe, Maxi, Jüttner, Madlen, Troschke-Meurer, Sascha, Lode, Holger N.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2017
Onderwerpen:
Original Research
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5665083/
https://ncbi.nlm.nih.gov/pubmed/29123953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1343775
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items